Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists
Xin Chen, John D. McCorvy, Matthew G. Fischer, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 23, pp. 10601-10618
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel, Silvia Gatti McArthur
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 190
Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
John D. McCorvy, Kyle V. Butler, Brendan Kelly, et al.
Nature Chemical Biology (2017) Vol. 14, Iss. 2, pp. 126-134
Open Access | Times Cited: 154
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential
Liang Tan, Wenzhong Yan, John D. McCorvy, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 22, pp. 9841-9878
Closed Access | Times Cited: 120
GPCR Biosensors to Study Conformational Dynamics and Signaling in Drug Discovery
Victoria R. Saca, Colin Burdette, Thomas P. Sakmar
The Annual Review of Pharmacology and Toxicology (2025) Vol. 65, Iss. 1, pp. 7-28
Closed Access | Times Cited: 1
Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation
Prashant Donthamsetti, Eduardo F. Gallo, David C. Buck, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 9, pp. 2086-2100
Open Access | Times Cited: 64
Classics in Chemical Neuroscience: Haloperidol
Marshall Tyler, Josefa Zaldivar-Díez, Stephen J. Haggarty
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 3, pp. 444-453
Closed Access | Times Cited: 63
2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts
Amy Hauck Newman, Francisco O. Battiti, Alessandro Bonifazi
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 5, pp. 1779-1797
Open Access | Times Cited: 62
Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs
Bryan L. Roth
Nature Structural & Molecular Biology (2019) Vol. 26, Iss. 7, pp. 535-544
Open Access | Times Cited: 61
Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties
Zhangcheng Chen, Luyu Fan, Huan Wang, et al.
Nature Neuroscience (2021) Vol. 25, Iss. 1, pp. 39-49
Closed Access | Times Cited: 49
Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure
Dorothée Möller, Ashutosh Banerjee, Taygun C. Uzuneser, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 7, pp. 2908-2929
Closed Access | Times Cited: 56
Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds
Amy E. Moritz, R. Benjamin Free, David R. Sibley
Cellular Signalling (2017) Vol. 41, pp. 75-81
Open Access | Times Cited: 56
Novel and Potent Dopamine D2 Receptor Go-Protein Biased Agonists
Alessandro Bonifazi, Hideaki Yano, Adrian M. Guerrero, et al.
ACS Pharmacology & Translational Science (2019) Vol. 2, Iss. 1, pp. 52-65
Open Access | Times Cited: 50
Strategies for the discovery of biased GPCR ligands
Marcel Bermúdez, Trung Ngoc Nguyen, Christian Omieczynski, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 4, pp. 1031-1037
Closed Access | Times Cited: 47
A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity
Marta Sánchez‐Soto, Ravi Kumar Verma, Blair K. A. Willette, et al.
Science Signaling (2020) Vol. 13, Iss. 617
Open Access | Times Cited: 41
Ligand-directed bias of G protein signaling at the dopamine D2 receptor
Ee Von Moo, Kasper Harpsøe, Alexander S. Hauser, et al.
Cell chemical biology (2021) Vol. 29, Iss. 2, pp. 226-238.e4
Open Access | Times Cited: 28
The histamine H3 receptor modulates dopamine D2 receptor–dependent signaling pathways and mouse behaviors
Jian Xu, Christopher Pittenger
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 104583-104583
Open Access | Times Cited: 11
Molecular Glues: A New Approach to Modulating GPCR Signaling Bias
Jamie Kushnir, Ryan H. Gumpper
Biochemistry (2025)
Open Access
Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library
Barbara Männel, Mariama Jaiteh, Alexey A. Zeifman, et al.
ACS Chemical Biology (2017) Vol. 12, Iss. 10, pp. 2652-2661
Closed Access | Times Cited: 35
A kinetic method for measuring agonist efficacy and ligand bias using high resolution biosensors and a kinetic data analysis framework
Sam R.J. Hoare, Paul Tewson, Anne Marie Quinn, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 31
Dopamine D1 Receptor in Cancer
Paweł Sobczuk, Michał Łomiak, Agnieszka Cudnoch‐Jędrzejewska
Cancers (2020) Vol. 12, Iss. 11, pp. 3232-3232
Open Access | Times Cited: 28
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
Radomír Jůza, Kamil Musílek, Eva Mezeiová, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 55-211
Closed Access | Times Cited: 17
Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D2 and D3 Receptors and Their Impact on Behavioral Sensitization
Kyeong‐Man Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6742-6742
Open Access | Times Cited: 10
Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity
Michael L. Martini, Caroline Ray, Xufen Yu, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 9, pp. 4160-4182
Open Access | Times Cited: 27
New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling
Anika Mann, Alastair C. Keen, Hanka Mark, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 21
Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased D2R Agonists
Barbara Männel, Daniela G. Dengler, Jeremy Shonberg, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 11, pp. 4693-4713
Closed Access | Times Cited: 28
Page 1 - Next Page

Scroll to top